Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

12
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
12
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

23
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
23
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

4.6K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.6K
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.9K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.9K
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

19
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
19
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

19
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
19

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated Pharmacometric Model Development by Leveraging Low-Dimensional Neural ODEs and LASSO Regression.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Evolution of thyroid surgery: unravelling complications from the 1930s to the modern era - a retrospective cohort study.

Swiss medical weekly·2026
Same author

Drug prescribing in critically ill children with kidney impairment: Comparing clinical practice with clinical decision support recommendations.

International journal of medical informatics·2026
Same author

Evaluation of adalimumab tapering regimens in children and adolescents with juvenile idiopathic arthritis in remission: a simulation study.

Pediatric rheumatology online journal·2026
Same author

Redefining Parameter Estimation and Covariate Selection via Variational Autoencoders: One Run Is All You Need.

CPT: pharmacometrics & systems pharmacology·2025
Same author

Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Analysis for Clazakizumab in Patients With End-Stage Kidney Disease Undergoing Dialysis.

Clinical and translational science·2025
Same journal

Asymptotic Regularity of a Generalised Stochastic Halpern Scheme.

Journal of optimization theory and applications·2026
Same journal

Optimal Multi-Drug Therapies for Antimicrobial Resistance with Horizontal Transfer.

Journal of optimization theory and applications·2026
Same journal

S-shaped Utility Maximization with VaR Constraint and Partial Information.

Journal of optimization theory and applications·2026
Same journal

A Positive Semidefinite Safe Approximation of Multivariate Distributionally Robust Constraints Determined by Simple Functions.

Journal of optimization theory and applications·2025
Same journal

Generalized Robust Optimization using the Notion of Set-Valued Probability.

Journal of optimization theory and applications·2025
Same journal

ABB Theorems: Results and Limitations in Infinite Dimensions.

Journal of optimization theory and applications·2025
See all related articles

Related Experiment Video

Updated: Oct 15, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.0K

OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control.

Freya Bachmann1, Gilbert Koch2, Marc Pfister2

  • 1Department of Mathematics and Statistics, University of Konstanz, Konstanz, Germany.

Journal of Optimization Theory and Applications
|November 1, 2021
PubMed
Summary
This summary is machine-generated.

We developed OptiDose, an algorithm for optimal drug dosing. It personalizes medication regimens using pharmacokinetic-pharmacodynamic models for better patient outcomes.

Keywords:
Individualized optimal drug dosingModel predictive controlOptimal controlPharmacokinetic–pharmacodynamic modelsQuasi-Newton methods

More Related Videos

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
12:41

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

5.2K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.8K

Related Experiment Videos

Last Updated: Oct 15, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.0K
Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
12:41

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

5.2K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.8K

Area of Science:

  • Pharmaceutical Sciences
  • Pharmacokinetics
  • Pharmacodynamics
  • Computational Biology

Background:

  • Individualized drug dosing is crucial for effective treatment and patient safety.
  • Current dosing strategies may not fully account for complex pharmacokinetic-pharmacodynamic (PK/PD) relationships.
  • Optimizing drug regimens requires sophisticated modeling approaches.

Purpose of the Study:

  • To develop and validate an optimal dosing algorithm (OptiDose) for individualized patient treatment.
  • To compute optimal dosing regimens using PK/PD models across diverse scenarios and administration routes.
  • To minimize a cost functional representing deviation from a desired therapeutic outcome.

Main Methods:

  • Developed an optimal control problem framework for PK/PD models.
  • Formulated drug doses as discrete controls within a finite-dimensional optimization problem.
  • Utilized adjoint techniques for efficient gradient computation.
  • Employed quasi-Newton methods for solving the optimization problem.

Main Results:

  • Successfully developed and validated the OptiDose algorithm.
  • Demonstrated the algorithm's applicability to three distinct PK/PD scenarios.
  • Efficiently computed optimal individualized dosing regimens.
  • Showcased the algorithm's robustness across various administration routes.

Conclusions:

  • OptiDose provides an effective computational approach for determining optimal individualized drug dosing regimens.
  • The algorithm integrates PK/PD modeling with optimal control theory for enhanced therapeutic strategies.
  • OptiDose has significant potential for application in clinical practice and pharmaceutical research.